Humate-P Drug Information [ Sanofi-Aventis; CSL ]
Table of content
Humate-P category:
Active ingredients:
Humate-P companies and manufacturers:
General Information
Humate-P forms, composition and dosages:
- Injectable; Injection; Antihemophilic Factor Human 300 units; Von Willebrand Factor Human 840 units / 5 ml
- Injectable; Injection; Antihemophilic Factor Human 600 units; Von Willebrand Factor Human 1,680 units / 10 ml
- Injectable; Injection; Antihemophilic Factor Human 1,200 units; Von Willebrand Factor Human 3,360 units / 15 ml
Indications, usages and classification codes:
- B02BD06 - Von Willebrand Factor and Coagulation Factor VIII in combinations
PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
- AHF CSL
- AHG BCM
- Aimafix Kedrion; Biosano Laboratorios; Onko & Kocsel Ilaclari; Riace Farma; Scott-Cassara
- Alpha VIII Alpha Therapeutic Corporation
- Alphanate Grifols; Alpha Therapeutic Corporation; Edward Keller; Great Year Trading
- Alphanine Alpha Therapeutic Corporation; Grifols
- Amcacid GlaxoSmithKline
- Amchafibrin Rottapharm
- Amikapron BCM
- Amofil Veripalvelu Suomen Punainen Risti
- Amstat BCM
- Antagosan Sanofi-Aventis
- Antihemophillic Factor Human Hemofil M, Method M, Monoclonal Purified Baxter
- Anti-Inhibitor Coagulant Complex Baxter; Teva
- Antilysin Spofa
- Anvitoff Abbott Laboratories
- Aprotex Veropharm; Lans-Pharm
- Auricid Day Farma
- Autoplex Baxter
- Autoplex T Baxter; Nabi Biopharmaceuticals; Teva; United Italian Trading